Хирургическое лечение вторичной недостаточности трехстворчатого клапана

Б.М. Тодуров, Г.И. Дарвиш, О.В. Зеленчук, М.Ф. Ротарь, И.В. Швец, Н.В. Понич, С.Н. Сагура

Література 

1. Дземешкевич С.Л., Стивенсон Л.У. Болезни митрального клапана. Функция, диагностика, лечение.– М.: ГЭОТАР Медицина, 2000.– C. 288.
2. Марченко С.П., Старчик Д.А. и др. Хирургическая анато­мия трикуспидального клапана // Патология крово­обращения и кардиохирургия.– 2007.– № 2.– С. 7–12.
3. Тодуров Б.М., Дарвиш Г.И. и др. Клеверная техника как новый метод коррекции трехстворчатой недостаточности у больных с хронической постэмболической легочной гипертензией // Укр. кардіол. журн.– 2008.– № 4.– С. 9–11.
4. Braunwald N.S., Ross J., Jr. Morrow A.G. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement // Circulation.– 1967.– Vol. 35 (4).– P. 63–69.
5. Carpentier A. Cardiac valve surgery – the «French correction» // J. Thorac. Cardiovasc. Surg.– 1983.– Vol. 86.– P. 323–337.
6. Carpentier A., Deloche A., Dauptain J. et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency // J. Thorac. Cardiovasc. Surg.– 1971.– Vol. 61.– P. 1–13.
7. Carpentier A., Deloche A., Hanania G. et al. Surgical management of acquired tricuspid valve disease // J. Thorac. Cardiovasc. Surg.– 1974.– Vol. 67.– P. 53–65.
8. Colombo T., Russo C., Ciliberto G.R. et al. Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair // Cardiovasc. Surg.– 2001.– Vol. 9.– P. 369–377.
9. De Vega N.G., De Rabago G., Castillon L. et al. A new tricuspid repair. Short-term clinical results in 23 cases // J. Cardio­vasc. Surg. (Torino).– 1973.– Spec. Vol.– P. 384–386.
10. Dreyfus G.D., Corbi P.J., Chan K.M., Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? // Ann. Thorac. Surg.– 2005.– Vol. 79.– P. 127–132.
11. Fukuda S., Gillinov A.M., Song J.M. et al. Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation // Am. Heart J.– 2006.– Vol. 152.– P. 1208–1214.
12. Fukuda S., Saracino G., Matsumura Y. et al. Three-dimensio­nal geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study // Circulation.– 2006.– Vol. 114 (1).– P. 492–498.
13. Groves P. H., Ikram S., Ingold U., Hall R.J. Tricuspid regurgitation following mitral valve replacement: an echocardiographic study // J. Heart Valve Dis.– 1993.– Vol. 2.– P. 273–278.
14. Groves P. H., Lewis N.P., Ikram S. et al. Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve di­sease // Br. Heart J.– 1991.– Vol. 66.– P. 295–301.
15. Kim H.K., Kim Y.J., Park J.S. et al. Determinants of the seve­rity of functional tricuspid regurgitation // Am. J. Cardiol.– 2006.– Vol. 98.– P. 236–242.
16. King R.M., Schaff H.V., Danielson G.K. et al. Surgery for tricuspid regurgitation late after mitral valve replacement // Circulation.– 1984.– Vol. 70.– P. 193–197.
17. Kuwaki K., Morishita K., Tsukamoto M., Abe T. Tricuspid valve surgery for functional tricuspid valve regurgitation associa­ted with left-sided valvular disease // Eur. J. Cardiothorac. Surg.– 2001.– Vol. 20.– P. 577–582.
18. Menzel T., Kramm T., Wagner S. et al. Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy // Ann. Thorac. Surg.– 2002.– Vol. 73.–P. 756–761.
19. Messer A.L., Hurst J.W., Rappaport M.B., Sprague H.B. A study of the venous pulse in tricuspid valve disease // Circulation.– 1950.– Vol. 1.– P. 388–393.
20. Mogollon M.V., Lage E., Cabezon S. et al. Combination the­rapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report // Transplant. Proc.– 2006.– Vol. 38.– P. 2522–2523.
21. Park Y.H., Song J.M., Lee E.Y. et al. Geometric and hemodynamic determinants of functional tricuspid regurgitation: a real-time three-dimensional echocardiography study // Int. J. Cardiol.– 2008.– Vol. 124.– Р. 160–165.
22. Rivera J.M., Vandervoort P.M., Vazquez de Prada J.A. et al. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? // Am. J. Cardiol.– 1993.– Vol. 72.– P. 1305–1309.
23. Sadeghi H.M., Kimura B.J., Raisinghani A. et al. Does lowering pulmonary arterial pressure eliminate severe functional tricuspid regurgitation? Insights from pulmonary thromboendarterectomy // J. Am. Coll. Cardiol.– 2004.– Vol. 44.– P. 126–132.
24. Sagie A., Schwammenthal E., Padial L.R. et al. Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients // J. Am. Coll. Cardiol.– 1994.– Vol. 24.– P. 446–453.
25. Sukmawan R., Watanabe N., Ogasawara Y. et al. Geometric changes of tricuspid valve tenting in tricuspid regurgitation secondary to pulmonary hypertension quantified by novel system with transthoracic real-time 3-dimensional echocardiography // J. Am. Soc. Echocardiogr.– 2007.– Vol. 20.– P. 470–476.
26. Tang G.H., David T.E., Singh S.K. et al. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes // Circulation.– 2006.– Vol. 114.– P. 577–581.
27. Tei C., Pilgrim J.P., Shah P. M. et al. The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation // Circulation.– 1982.– Vol. 66.– P. 665–671.
28. Ton-Nu T.T., Levine R.A., Handschumacher M.D. et al. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography // Circulation.– 2006.– Vol. 114.– P. 143–149.

Ішемічна мітральна недостатність: сучасний стан проблеми

Н.Д. Орищин, Ю.А. Іванів

Література 

1. Agricola E., Oppizzi M., Maisano F. et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern // Eur. J. Echocardiogr.– 2004.– Vol. 5.– P. 326–334.
2. Agricola E., Oppizzi M., Pisani M. et al. Ischemic mitral regurgitation: mechanisms and echocardiographic classification // Eur. J. Echocardiogr.– 2008.– Vol. 9.– P.207–221.
3. Agricola E., Ielasi A., Oppizzi M. et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction // Eur. J. Heart Fail.– 2009.– Vol. 11.– P. 581-587.
4. Aklog L., Filsoufi F., Flores K.Q. et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? // Circulation.– 2001.– Vol. 104.– P. 168–175.
5. Amigoni M., Meris A., Thune J.J. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function // Eur. Heart J.– 2007.– Vol. 28.– P. 326–333.
6. Bach D.S., Deeb G.M., Bolling S.F. Accuracy of intraoperative transesophageal echocardiography for estimating the severity of functional mitral regurgitation // Am. J. Cardiol.– 1995.– Vol. 76.– P. 508–512.
7. Benedetto U., Melina G. et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. // J Cardiovasc. Med.– 2009.– Vol. 10 (2).– P. 109–114.
8. Burch G.E., DePasquale N.P., Phillips J.H. et al. The syndrome of papillary muscle dysfunction // Am. Heart J.– 1968.– Vol. 75.– P. 399–415.
9. Bursi F., Enriquez-Sarano M., Nkomo V.T. et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation // Circulation.– 2005.– Vol. 111.– P. 295–301.
10. Calafiore A.M., Gallina S., Di Mauro M. et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? // Ann Thorac Surg.– 2001.– Vol. 71.– P. 1146–1153.
11. Ciarka A., Braun J. et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty // Am. J. Cardiol. – 2010.– Vol. 106(3).– P. 395–401.
12. Chan V., Ruel M., Mesana T.G. Mitral valve replacement is a viable alternative to mitral valve repair for ischemic mitral regurgitation: a case-matched study // Ann. Thorac. Surg.– 2011.– Vol. 92.– P. 1358–1366.
13. Deja M.A., Grayburn P.A., Sun B. et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial // Circulation.– 2012.– Vol. 125.– P. 2639–2648.
14. Dent J.M., Spotnitz W.D., Nolan S.P. et al. Mechanism of mitral leaflet excursion // Am. J. Physiol.– 1995.– Vol. 269.– P. 2100–2108.
15. Enriquez-Sarano M., Miller F.J., Hayes S. et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method // J. Am. Coll. Cardiol.– 1995.– Vol. 25.– P. 703–709.
16. Gorman R.C., McCaughan J.S., Ratcliffe M.B. et al. Patho­genesis of acute ischemic mitral regurgitation in three dimensions // J. Thorac. Cardiovasc. Surg.– 1995.– Vol. 109.– P. 684–693.
17. Gorman J.H., Jackson B.M., Enomoto Y., Gorman R.C. The effect of regional ischemia on mitral valve annular saddle shape // Ann. Thorac. Surg.– 2004.– Vol. 77.– P. 544–548.
18. Godley R.W., Wann L.S., Rogers E.W. et al. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction // Circulation.– 1981.– Vol. 63.– P. 565–571.
19. Grigioni F., Enriquez-Sarano M., Zehr K.J. et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment // Circulation.– 2001.– Vol. 103.– P. 1759–1764.
20. Grossi E.A., Crooke G.A. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization // Circulation. – 2006.– Vol. 114 (Suppl.).– P. I573–1576.
21. Hall S.A., Brickner E,. Willett D.L. et al. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta // Circulation.– 1997.– Vol. 95.– P. 636–642.
22. He S., Fontaine A.A., Schwammenthal E. et al. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies // Circulation.– 1997.– Vol. 96.– P. 1826–1834.
23. Hickey M.S., Smith L.R., Muhlbaier L.H. et al. Current prognosis of ischemic mitral regurgitation: Implications for future management // Circulation.– 1988.– Vol. 78.– P. 1–51.
24. Hung J., Papakostas L., Tahta S.A. et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: conti­nued LV remodeling as a moving target // Circulation.– 2004.– Vol. 110 (Suppl. II).– P. 85–90.
25. Kaji S., Nasu M., Yamamuro A. et al. Annular Geometry in Patients With Chronic Ischemic Mitral Regurgitation // Circulation.– 2005.– Vol. 112.– P. 409–414.
26. Kanzaki H., Bazaz R., Schwartzman D. et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy // J. Am. Coll. Cardiol.– 2004.– Vol. 44.– P. 1619–1625.
27. Kaul S., Spotnitz W.D., Glasheen W.P., Touchstone D.A. Mechanism of ischemic mitral regurgitation: an experimental evaluation // Circulation.– 1991.– Vol. 84.– P. 2167–2180.
28. Keren G., Katz S., Strom J. et al. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure // Circulation.– 1989.– Vol. 80.– P. 306–313.
29. Kono T., Sabbah H.N., Rosman H. et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure // J. Am. Coll. Cardiol.– 1992.– Vol. 20.– P. 1594–1598.
30. Kumanohoso T., Otsuji Y., Yoshifuku S. et al. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction // J. Thorac. Cardiovasc. Surg.– 2003.– Vol. 125.– P.135–143.
31. Kwan J., Shiota T., Agler D.A. et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study // Circulation.– 2003.– Vol. 107.– P. 1135–1140.
32. Lamas G.A., Mitchell G.F., Flaker G.C. et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators // Circulation.– 1997.– Vol. 96.– P. 827–833.
33. Lancellotti P., Lebrun F., Pierard L.A. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction // J. Am. Coll. Cardiol.– 2003.– Vol. 42.– P. 1921–1928.
34. Lancellotti P., Gérard P.L., Piérard L.A. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation // Eur. Heart J.– 2005.– Vol. 26.– P. 1528–1532.
35. Lehmann K.G., Francis C.K., Dodge H.T. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group // Ann. Intern. Med.– 1992.– Vol. 117.– P.10–17.
36. Liel-Cohen N., Guerrero J.L., Otsuji Y. et al. Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from three-dimensional echocardiography // Circulation.– 2000.– Vol. 101.– P. 2756-2763.
37. Madaric J., Vanderheyden M., Van Laethem C. et al. Early and late effects of cardiac resynchronization therapy on exercise induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance // Eur. Heart. J.– 2007.– Vol. 28.– P. 2134–2141.
38. Mittal A.K., Langston M.Jr, Cohn K.E. et al. Combined papillary muscle and left ventricular wall dysfunction as a cause of mitral regurgitation: an experimental study // Circulation.– 1971.– Vol. 44.– P. 174–180.
39. Otsuji Y., Handschumacher M., Schwammenthal E. et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry // Circulation.– 1997.– Vol. 96.– P. 1999–2008.
40. Otsuji Y., Gilon D., Jiang L. et al. Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction: evidence for increased valve tethering // J. Am. Coll. Cardiol.– 1998.– Vol. 32.– P. 398–404.
41. Otsuji Y., Kumanohoso T,. Yoshifuku S. et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy // J. Am. Coll. Cardiol.– 2002.– Vol. 39.– P. 1651–1656.
42. Pierard L.A., Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema // N. Engl. J. Med.– 2004.– Vol. 351.– P. 1627–1634.
43. Porciani M.C., Macioce R., Demarchi G. et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure // Eur. J. Echocardiogr.– 2006.– Vol. 7.– P. 31–39.
44. Sabbah H.N., Rosman H., Kono T. et al. On the mechanism of functional mitral regurgitatio // Am. J. Cardiol.– 1993.– Vol. 72.– P. 1074–1076.
45. Schroder J.N., Williams M.L., Hata J.A. et al. Impact of Mitral Valve Regurgitation Evaluated by Intraoperative Transesophageal Echocardiography on Long-Term Outcomes After Coronary Artery Bypass Grafting // Circulation.– 2005.– Vol. 112.– P. 293–298.
46. Yiu S.F., Enriquez-Sarano M., Tribouilloy C. et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study // Circulation.– 2000.– Vol. 102.– P. 1400–1406.
47. Zoghbi W.A., Enriquez-Sarano M., Foster E. et al. American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography // J. Am. Soc. Echocardiog.– 2003.– Vol. 16.– P. 777–802.
48. Vahanian A., Baumgartner H., Bax J. et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology // Eur. Heart J.– 2007.– Vol. 28.– P. 230–268.
49. Varennes B., Chaturvedi R., Sidhu S. et al. Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation // Circulation.– 2009.– Vol. 119.– P. 2837–2843.

Еволюція рекомендацій з медикаментозного та хірургічного лікування серцевої недостатності

О.Й. Жарінов

Література 

1. McMurray J.J.V. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 // Eur. Heart J.– 2012.– DOI: 10.1093/eurheartj/ehs104.
2. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 // Eur. Heart J.– 2008.– Vol. 29.– P. 2388–2442.

Консенсус експертів: денервація нирок для лікування артеріальної гіпертензії

Atul Pathak, Xavier Girerd, Michel Azizi, Hakim Benamer, Jean-Michel Halimi, Pierre Lantelme, Thierry Lefevre, Mark Sapoval, від імені Французького товариства з артеріальної гіпертензії, Французького товариства кардіологів, робочої групи з атероми та інтервенційної кардіології Французького товариства радіологів

Література 

1. Bisognano J.D, Bakris G., Nadim M.K. et al. Baroreflex activa­tion therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial // J. Amer. Coll. Cardiol.– 2011.– Vol. 58.– P. 765–773.
2. Calhoun D.A., Jones D., Textor S. et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research // Circulation.– 2008.– Vol. 117.– P. e510–526.
3. Daugherty S.L., Powers J.D., Magid D.J. et al. Incidence and prognosis of resistant hypertension in hypertensive patients // Circulation.– 2012.– Vol. 125.– P. 1635–1642.
4. DiBona G.F. Neural control of the kidney: past, present, and future // Hypertension.– 2003.– Vol. 41.– P. 621–624.
5. DiBona G.F., Esler M. Translational medicine: the antihyper­ten­sive effect of renal denervation // Amer. J. Physiol. Regul. Integr. Comp. Physiol.– 2010.– Vol. 298.– P. R245–253.
6. Esler M.D., Krum H., Sobotka P.A. et al. Renal sympathetic dener­vation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial // Lancet.– 2010.– Vol. 376.– P. 1903–1909.
7. Evelyn K.A., Singh M.M., Chapman W.P. et al. Effect of thoracolum­bar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects // Amer. J. Med.– 1960.– Vol. 28.– P. 188–221.
8. Godet-Mardirossian H., Girerd X., Vernay M. et al. Patterns of hypertension management in France (ENNS 2006-2007) // Eur. J. Prev. Cardiol.– 2012.– Vol. 19.– P. 213–220.
9. Hausberg M., Kosch M., Harmelink P. et al. Sympathetic nerve activity in end-stage renal disease // Circulation.– 2002.– Vol. 106.– P. 1974–1979.
10. Joyner M.J., Charkoudian N., Wallin B.G. Sympathetic nervous sys­tem and blood pressure in humans: individualized patterns of regulation and their implications // Hyperten­sion.– 2010.– Vol. 56.– P. 10–16.
11. Katholi R.E., Whitlow P.L., Winternitz S.R. et al. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension // Hypertension.– 1982.– Vol. 4.– P. 166–174.
12. Krause T., Lovibond K., Caulfield M. et al. Management of hyper­tension: summary of NICE guidance // Brit. Med. J.– 2011.– Vol. 343.– P. d4891.
13. Krum H., Schlaich M., Sobotka P. et al. Novel procedure- and device-based strategies in the management of systemic hyper­tension // Eur. Heart J.– 2011.– Vol. 32.– P. 537–544.
14. Krum H., Schlaich M., Whitbourn R. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a mul­ticentre safety and proof-of-principle cohort study // Lancet.– 2009.– Vol. 373.– P. 1275–1281.
15. Morrissey D.M., Brookes V.S., Cooke W.T. Sympathectomy in the treatment of hypertension; review of 122 cases // Lancet.– 1953.– Vol. 1.– P. 403–408.
16. Persell S.D. Prevalence of resistant hypertension in the United States, 2003–2008 // Hypertension.– 2011.– Vol. 57.– P. 1076–1080.
17. Simplicity HTN-1 Investigators 2011. Catheter-based renal sym­pathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension. 2011.– Vol. 57.– P. 911–917.
18. Smithwick R.H., Thompson J.E. Splanchnicectomy for essen­tial hypertension; results in 1,266 cases // J. Amer. Med. Assoc.– 1953.– Vol. 152.– P. 1501–1504.

Лікування хронічних оклюзій лівої підключичної артерії методом реканалізації з подальшим стентуванням

А.В. Хохлов, А.О. Максаков, Хоррам Сохраб, М.В. Шиманко

Література 

1. Бокерия Л.Ю., Алекян Б.Г. Руководство по рентген­эндоваскулярной хирургии сердца и сосудов.– М., 2008.– Т. 1.– С. 175–193.
2. Alegret R.E., Blandon R.J., Kirsch J. Poor left internal mammary artery opacification on coronary CT angiography: an indirect sign of subclavian steal // J. Vasc. Interv. Radiol.– 2008.– Vol. 19 (12).– P. 1791–1792.
3. Bauer A.M., Amin-Hanjani S., Alaraj A., Charbel F.T. Quantitative magnetic resonance angiography in the evaluation of the subclavian steal syndrome: report of 5 patients // J. Neuroimaging.– 2009.– Vol. 19 (3).– P. 250–252.
4. De Vries J.P., Jager L.C., Van den Berg J.C. et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results // J. Vasc. Surg.– 2008.– Vol. 41 (1).– P. 19–23.
5. Govedarski V., Genadiev S., Nedevska M. et al. Endovascular recanalisation of subclavian artery stenotic-occlusive lesions // Khirurgiia (Sofiia).– 2008.– P. 30–33.
6. Harper C., Cardullo P.A., Weyman A.K., Patterson R.B. Transcranial Doppler ultrasonography of the basilar artery in patients with retrograde vertebral artery flow // J. Vasc. Surg.– 2008.– Vol. 48 (4).– P. 859–864.
7. Takach T.J., Reul G.J., Cooley D.A. et al. Myocardial thievery: the coronary-subclavian steal syndrome // Ann. Thorac. Surg.– 2009.– Vol. 81 (1).– P. 386–392.

Неотложная реваскуляризация и послеоперационное ведение пациента с острым инфарктом миокарда и рецидивирующей желудочковой тахикардией /фибрилляцией желудочков

А.А. Долгова, И.Н. Кузьмич, В.А. Шевченко, А.В. Хохлов, А.Н. Грицай, Е.М. Боярчук, И.В. Чухлеб, А.В. Пинчук, О.А. Епанчинцева

Література 

1. Al-Khatib S.M., Stebbins A.L., Califf R.M. et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial // Amer. Heart J.– 2003.– Vol. 145.– P. 515–521.
2. Antman E.M., Anbe D.T., Armstrong P.W. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction) // J. Amer. Coll. Cardiol.– 2004.– Vol. 44.– P. e1–211.
3. Campbell R.W.F. Arrhythmias // Management of acute myocardial infarction / Eds. D.G. Julian, E. Braunwald.– London: WB Saunders Co. Ltd, 1994.– P. 223–240.
4. Fares W.H., Aneja A. Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure? // Cleve Clin. J. Med. – 2006.– Vol. 73 (6).– P. 557–559.
5. Fonarow G.C., Abraham W.T., Albert N.M. et al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design // Amer. Heart J.– 2004.– Vol. 148.– P. 43–51.
6. Gattis W.A., O’Connor C.M., Gallup D.S. et al. IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial // J. Amer. Coll. Cardiol.– 2004.– Vol. 43.– P. 1534–1541.
7. Gattis W.A., O’Connor C.M., Leimberger J.D. et al. Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure // Amer. J. Cardiol.– 2003.– Vol. 91.– P. 169–174.
8. Hunt S.A. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) // J. Amer. Coll. Cardiol.– 2005.– Vol. 46.– P. 1–82.
9. Lowes B.D., Simon M.A., Tsvetkova T.O., Bristow M.R. Inotropes in the beta-blocker era // Clin. Cardiol. – 2000.– Vol. 23 (Suppl. 3).– P. 11–16.
10. Newby K.H., Thompson T., Stebbins A. et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes // Circulation.– 1998.– Vol. 98.– P. 2567–2573.
11. Nieminen M.S., Böhm M., Cowie M.R. et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology // Eur. Heart J. – 2005.– Vol. 26 (4).– P. 384–416.
12. Oh Y.J., Lee J.H., Kim J.Y. et al. The haemodynamic effects of propranolol and atenolol medication on dobutamine infusion in patients with coronary artery obstructive disease // J. Int. Med. Res. – 2005.– Vol. 33 (3).– P. 329–336.
13. Priori G.S., Blanc J.-J., Budaj A. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) // J. Amer. Coll. Cardiol.– 2006.– Vol. 48, N 5.– P. 247–346.
14. Tarantini L., Cioffi G., Opasich C. et al. Pre-discharge initiation of beta-blocker therapy in elderly patients hospita­lized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure // Ital. Heart J.– 2004.– Vol. 5.– P. 441–449.
15. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology // Eur. Heart J.– 2008.– Vol. 29 (23).– P. 2909–2945.

Фактори ризику виникнення раптової серцевої смерті у хворих з гіпертрофічною кардіоміопатією

В.Й. Целуйко, О.О. Бутко

Література 

1. Целуйко В.И., Ковалевская О.С. Гипертрофическая кардиомиопатия: методическое пособие в таблицах и схемах.– Х.: Гриф, 1999.– 204 с.
2. Elliott P., Spirito P.Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice // Heart.– 2008.– N 94.– Р. 1269–1275.
3. Elliott P.M., Gimeno Blanes J.R., Mahon N.G. et al. Relation between severity of leftventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy // Lancet.– 2001.– N 357.– Р. 420–424.
4. Elliott P.M., Gimeno J.R., Tome M.T. et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy // Eur Heart J.– 2006.– N 27.– Р. 1933–1941.
5. Hughes S.E. The pathology of hypertrophic cardiomyopathy // Histopathology.– 2004.– N 44.– Р. 412–427.
6. Maron B.J., McKenna W.J., Danielson G.K. et al. Clinical expert consensus document on hypertrophic cardiomyopathy ACC/ESC // Eur. Heart. J.– 2003.– Vol. 24.– P. 1965–1991.
7. Maron B.J., Pelliccia A. The heart of trained athletes cardiac remodeling and the risks of sports, including sudden death // Circulation.– 2006.– N 114.– Р. 1633–1644.
8. Maron B.J., Spirito P., Shen W.K. et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy // JAMA.– 2007.– N 298 (4).– Р. 405–412.
9. Ostman-Smith I., Wettrell G., Keeton B. et al. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy // Eur. Heart J.– 2008.– N 29.– Р. 1160–1167.
10. Spirito P., Bellone P., Harris K.M. et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy // New Engl. J. Med.– 2000.– N 342.– Р. 1778–1785.
11. Tsoutsman T., Lam L., Semsarian C. Genes, calcium and modifying factors in hypertrophic cardiomyopathy // Clin. Exp. Pharmacol. Physiol.– 2006.– N 33.– Р. 139–145.
12. Woo A., Monakier D., Harris L. et al. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy // Heart.– 2007.– N 93.– Р. 1044–1045.

Оценка постнагрузки на единственный желудочек сердца с целью прогнозирования отдаленных результатов операции Fontan

М.Ф. Зиньковский, Р.Р. Сейдаметов, Б.В. Бацак, А.М. Довгань, М.Ю. Атаманюк, J. Moll, Е.М. Трембовецкая, С.Е. Дыкуха, К.Б. Бабаджанов

Література 

1. Зиньковский М.Ф. Врожденные пороки сердца. Ру­­ко­водство.– К.: Книга-плюс, 2010.– 1200 с.
2. Фейгенбаум Х. Эхокардиграфия / Пер. с англ. В.В. Ми­­ть­кова.– М.: Видар, 1999.– 511 с.
3. Jonas R. Comprehensive surgical management of congenital heart disease // Arnold, 2004.– P. 460.
4. Khongphatthanayothin A., Rattanawilaisak K., Benja­cholamas V. Clinical course and outcome of children with single ventricle physiology at King Chulalongkorn Memorial Hospital // J. Med. Assoc. Thai.– 2006.– Vol. 89 (9).– P. 1420–1426.
5. Hosein R.B.M., Clarke A.J.B., McGuirk S.P. et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The ‘Two Commandments’? // Eur. J. Cardiothoracic Surg.– 2007.– N 31.– P. 344–353.
6. Choussat F., Fontan F., Besse P. et al. Selection criteria for Fontan’s procedure // Рediatric. Cardiology / Eds. R.H. Anderson, E.A. Shinebourne.– Edinburg: Churchill Living­stone, 1978.– P. 559–566.
7. Setty S.P., Herrington C.S. Fontan procedure: old lessons and new frontiers // Expert Rev. Cardiovasc. Ther.– 2006.– Vol. 4 (4).– P. 515–521.

Случай успешного хирургического лечения ишемической болезни сердца и эпикардиальной липомы

Б.М. Тодуров, В.П. Захарова, Н.В. Шателен, М.Д. Глагола, Н.В. Понич, А.С. Болгова, С.Н. Судакевич, В.Б. Демянчук

Література 

1. Bardakci H., Altintas G., Unal U. et al. Giant cardiac lipoma: report of a case // J. Card. Surg.– 2008.– Vol. 23.– P. 254–256.
2. Becker A.E. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians // Pediatr. Cardiol.– 2000.– Vol. 21 (4).– P. 317–323.
3. Behnam R., Williams G., Gerlis L. et al. Lipoma of the mitral valve and papillary muscle // Amer. J. Cardiol.– 1983.– Vol. 51.– P. 1459.
4. Cooley D.A, Hehrlein F.W., Dapper F. Surgical treatment of cardiac neoplasms: 32-year experience. Tumors of the heart. Proceedings of the third symposium on cardiac surgery // Thorac. Сardiovasc. Surg.– 1990.– Vol. 38 (Special Issue).– P. 176–182.
5. Crockett J. E., Decker D., Reed W. et al. Lipoma of the heart // Amer. J. Cardiol.– 1964.– Vol. 14.– P. 39.
6. Dollar A.L., Wallace R.B., Kent K.M. et al. Mitral valve replacement for mitral lipoma associated with severe obesity // Amer. J. Cardiol.– 1989.– Vol. 64.– P. 1405–1407.
7. Fernandes F., Soufen H.N., Ianni B.M. et al. Primary neoplasms of the heart. Clinical and histological presentation of 50cases // Arq. Bras. Cardiol.– 2001.– Vol.76, N. 3.– P. 231–237.
8. Galen P.V. Jr., Breyer R., Holliday R. et al. Tumors of the heart surgical considerations // J. Cardiovasc. Surg.– 1984.– Vol. 25.– P. 5.
9. Hananouchi G.I., Goff W.B. Cardiac lipoma: six-year follow-up with MRI characteristics, and a review of the literature // Magn. Res. Imag.– 1990.– Vol. 8.– P. 825–828.
10. Heath D. Pathology of cardiac tumors // Amer. J. Cardiol.– 1968.– Vol. 21.– P. 315–327.
11. Maurer E.R. Successful removal of tumor of the heart // J. Thorac. Surg.– 1952.– Vol. 23.– P. 479–485.
12. McAllister H.A.Jr. Tumors of the heart and pericardium // Cardiovascular Pathollogy / Ed. M.D. Silver.– 2nd ed.– N.Y.: Churchill Livinstone Inc., 1991.– P. 1297–1333.
13. Monsseaux E., Idy-Peretti I., Bittoun J. et al. MR tissue characterization of a right atrial mass: diagnosis of a lipoma // J. Comput. Assist. Tomogr.– 1992.– Vol. 16.– P. 148–151.
14. Morikami Y., Higashi T. et al. Cardiac lipoma with changes of ST segment and T wave on electrocardiogram // Jap. Circulation J.– 1984.– Vol. 58.– P. 733–736.
15. O’Connor S., Recavarren R., Nichols L.C, Parwani A.V. Lipoma­tous hypertrophy of the interatrial septum: an overview // Arch. Pathol. Lab. Med.– 2006.– Vol. 130 (3).– P. 397–399.
16. Reece I.J., Cooley D.A., Frazier O.H. et al. Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients // J. Thorac. Cardiovasc. Surg.– 1984.– Vol. 88.– P. 439–446.
17. Rivera-Davila A.D., Rodriguez-Ospina L. Frequency of primary tumors of the heart // Bol. Asoc. Med. R.– 2008.– Vol. 100.– P. 48–54.
18. Silveira W.L., Nery M.W., Soares E.C.G. et al. Lipoma of the right atrium // Arq. Bras. Cardiol.– 2001.– Vol. 77, N. 4.– P. 365–368.
19. Smith D.N., Shaffer K., Patz E.F. Imaging features of nonmyxomatous primary neoplasms of the heart and pericardium // Clinical Imaging.– 1998.– Vol. 22, N. 1.– P. 15–22.
20. Zamir D., Pelled B., Marin G., Weiner P. Cardiac lipoma of the septum with systemic and pulmonary emboli // Harefuah.– 1995.– Vol. 129.– P. 179–181, 223.

Трипередсердне серце як діагностична знахідка у пацієнта похилого віку з постійною формою фібриляції передсердь

Н.В. Понич, Л.М. Дюбенко, І.О. Аксьонова, О.А. Єпанчінцева, О.Й. Жарінов, Б.М. Тодуров

Література 

1. Bassareo P.P., Tumbarello R., Mercuro G. Cor triatriatum and lipomatous hypertrophy of the interatrial septum in the elderly: a case report // Cardiovasc. Ultrasound.– 2010.– Vol. 9.– P. 8–14.
2. Einav E., Perk G., Kronzon I. Three-dimensional transthoracic echocardiographic evaluation of cor triatriatum // Eur. J. Echocardiogr.– 2008.– Vol. 9 (1).– P. 110–112.
3. Jegier W., Cibbons J.E., Wiglesworth F.W. Cor triatriatum: clinical, hemodynamic, and pathologic studies – surgical correction in early life // Pediatrics.– 1963.– Vol. 31.– P. 255–267.
4. Malik A., Fram D., Mohani A. et al. Cor triatriatum: a multimodality imaging approach // Can. J. Cardiol.– 2008.– Vol. 24 (3).– P. 19–20.
5. Moss and adam’s heart disease in infants, children and adolescents.– 6th ed.– Philadelphia: Lippincott, 2000.
6. Snider A. Echocardiography in pediatric heart disease.– 2nd ed.– Baltimore: C.V. Mosby Co, 1992.
7. Su C.S., Tsai I.C., Lin W.W. et al. Usefulness of multidetector-row computed tomography in evaluating adult cor triatriatum // Tex. Heart Inst. J.– 2008.– Vol. 35 (3).– P. 349–351.
8. Thakrar A., Shapiro M.D., Jassal D.S. et al. Cor triatriatum: the utility of cardiovascular imaging // Can. J. Cardiol.– 2007.– Vol. 23 (2).– P. 143–145.

Электрокардиограмма в диагностике инфаркта миокарда

Н.Т. Ватутин, Н.В. Калинкина, Е.В. Ещенко

Література 

1. Ватутин Н.Т. Кардиология.– Д.: Каштан, 2008.– 446 с.
2. Ватутин Н.Т. Неотложная кардиология.– Д., 2011.– 236 с.
3. Гринь В.К., Костогрыз В.Б., Романенко Р.Н., Столика О.И. Острый инфаркт миокарда с подъемом сегмента ST.– Донецк: Новый мир, 2010.– 74 с.
4. Agarwal J.B., Khaw K., Aurignac F., LoCurto A. Importance of posterior chest leads in patients with suspected myocardial infarction, but non-diagnostic 12-lead electrocardiogram // Amer. J. Cardiol.– 1999.– Vol. 83.– P. 323–326.
5. Antman E.M., Anbe D.T., Armstrong P.W. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) 2004 // J. Amer. Coll. Cardiol.– 2004.– Vol. 44.– Р. 671–719.
6. Bayes de Luna A., Wagner G., Birnbaum Y. et al. A new terminology for the left ventricular walls and for the location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging. A statement for healthcare professionals from a Committee appointed by the International Society for Holler and Noninvasive Electrocardiography // Circulation.– 2006.– Vol. 114. – Р. 1755–1760.
7. Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide­lines (Committee on the Management of Patients with Unstable Angina) 2002 // J. Amer. Colt. Cardiol.– 2002.– N 40.– Р. 1366–1374.
8. Ekmekci A., Toyoshima H., Kwoczynski J.K. et al. Angina pectoris V. Giant R wave and receding S wave in myocardial ischemia and certain non-ischemic conditions // Amer. J. Cardiol.– 1961.– Vol. 7.– Р. 521–532.
9. Engelen D.J., Gorgels A.P., Cheriex E.C. et al. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction // J. Amer. Coll. Cardiol.– 1999.– Vol. 34.– Р. 389–395.
10. Holland R.P., Brooks H. Precordial and epicardial surface potentials during myocardial ischemia in the pig. A theoretical and experimental analysis of the TQ and ST segments // Circ. Res.– 1975.– Vol. 37.– Р. 471–480.
11. Horan L.G., Flowers N.C., Johnson J.C. Significance of the diagnostic Q-wave of myocardial infarction // Circulation.– 1971.– Vol. 43.– Р. 428–436.
12. Kligfield P., Gettes L.S., Bailey J.J. et al. Recommendations for the standardization and interpretation of the electrocardiogram. Part I: the electrocardiogram and its technology. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society // Circulation.– 2007.– Vol. 115.– Р. 1306–1324.
13. Lopez-Sendon J., Coma-Canella I., Alcasena S. et al. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2 and V3 // J. Amer. Coll. Cardiol.– 1985.– Vol. 6.– Р. 1273–1279.
14. Luepker R.V., Apple F.S., Christenson R.H. et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Commit­tee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute // Circulation.– 2003.– Vol. 108.– Р. 2543–2549.
15. Matetzky S., Barbash G.I., Rabinowitz B. et al. Q-wave and non Q-wave myocardial infarction after thrombolysis // J. Amer. Coll. Card.– 1995.– Vol. 26.– Р. 1445–1451.
16. Matetzky S., Freimark D., Feinberg M.S. et al. Acute myocardial infarction with isolated ST segment elevation in posterior chest leads V7–V9. Hidden ST-segment elevations revealing acute posterior infarction // J. Amer. Coll. Cardiol.– 1999.– Vol. 34.– Р. 748–753.
17. Pahlm U.S., Chaitman B.R., Rautaharju P.M. et al. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle // Amer. J. Cardiol.– 1998.– Vol. 81.– Р. 809–815.
18. Porela P., Helenius H., Pulkki K., Voipio-Pulkki L.M. Epidemiological classification of acute myocardial infarction: time for a change? // Eur. Heart J.– 1999.– Vol. 20.– Р. 1459–1464.
19. Rautaharju P.M., Park L.P., Chaitman B.R. et al. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression // J. Electro­cardiol.– 1998.– Vol. 31.– Р. 157–187.
20. Richeson J.F., Akiyama T., Schenk E. A solid angle analysis of the epicardial ischemic TQ-ST deflection in the pig. A theoretical and experimental study // Circ. Res.– 1978.– Vol. 43.– Р. 879–888.
21. Savage R.M., Wagner G.S., Ideker R.E. et al. Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts // Circulation.– 1977.– Vol. 55.– Р. 279–285.
22. Sgarbossa E.B., Pinsky S.L. Barbagelata A. et al. Electro­cardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block // N. Engl. J. Med.– 1996.– Vol. 334.– Р. 481–487.
23. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined – A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction // Eur. Heart J.– 2000.– Vol. 21.– Р. 1502–1513.
24. Thygesen K., Alpert J.S., White H.D. et al. on behalf of the Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction // Eur. Heart J.– 2007.– Vol. 28 (20).– P. 2525–2538.
25. Wang K., Asinger R.W., Marriott H.J. ST-segment elevation in conditions other than acute myocardial infarction // N. Engl. J. Med.– 2003.–Vol. 349.– Р. 2128–2135.
26. Wong C.K., French J.K., Aylward P.E. et al. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogenous outcomes depending on the presence of ST-segment changes // J. Amer. Coll. Cardiol.– 2005.– Vol. 46.– Р. 29–38.
27. Yokoyama Y., Chaitman B.R., Hardison R.M. et al. Association between new ECG abnormalities after coronary revascula­rization and five year cardiac mortality in BARI randomized and registry patients // Amer. J. Cardiol.– 2000.–Vol. 86.– Р. 819–824.
28. Zimetbaum P.J., Josephson M.E. Use of the electrocardiogram in acute myocardial infarction // N. Engl. J. Med.– 2003.– Vol. 348.– Р. 933–940.
29. Zimetbaum P.J., Krishnan S., Gold A. et al. Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction // Amer. J. Cardiol.– 1998.– Vol. 81.– Р. 918–919.